Navigation Links
Genous in Medical Technology

Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents

Risk of Late Thrombosis is Minimized with Genous Stent BARCELONA, Spain, May 23, 2007 /PRNewswire/ -- The efficacy of OrbusNeich's Genous(TM) Bio-engineered R stent compares favorably to that of drug-eluting stents, while the risk of late thrombosis is minimized with the Genous stent, according to...

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents

...ble results in patients treated with the company's genous Bio-engineered R stent, the world's first pro-heal...scularization (TLR) rates (15.3% vs 13.7%) for the genous Bio-engineered R stent compared to Boston Scientif...hromboses. There were no thrombotic events in the genous treated group at any time period (0.0%). Myocardi...

Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)

...nd efficacy in the real-world use of the company's genous Bio-engineered R stent. Presented by Professor R...te of 8.5%. "The data further support the use of genous as an alternative to drug- eluting stents, especia...stry with 5,000 enrolled patients treated with the genous Bio-engineered R stent. The study protocol recomme...

Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008

... the world's first pro-healing stent, OrbusNeich's genous Bio-engineered R stent, will be presented next wee...cademic Medical Center in Amsterdam will provide a genous clinical program update in an oral presentation at...a Real World Experience in Patients Treated with a genous EPC Capturing Stent," the poster will reflect the ...

Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents

... of Interventional Cardiology demonstrate that the genous Bio-engineered R stent has better outcomes when co...percutaneous coronary intervention with either the genous stent or a TAXUS(R) and CYPHER(R) stent at the uni...rsus 5.8% for DES. "Our results suggest that the genous Bio-engineered R stent is safe and effective in hi...

Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents

...m at EuroPCR 2008 support the use of the company's genous Bio-engineered R stent, the world's first pro-heal...(TVF) rates at 12-month follow-up for OrbusNeich's genous Bio-engineered R stent and Boston Scientific's Tax...events, while there were no reported events in the genous group. TRIAS HR Pilot is a randomized, 193-patient...

Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008

...nth follow up data on 78 patients treated with the genous stent. Jonathan Hill, M.D., of King's College, L...Hospital, Singapore will present on the use of the genous Bio-engineered R stent in acute myocardial infarct... single blind study called TRIAS HR Pilot with the genous stent randomized with a drug eluting stent. In add...

Clinical Impact of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology

... of the first-ever pro-healing stent, OrbusNeich's genous Bio-engineered R stent, is the subject of a sympos....-1:35 p.m. -- The latest clinical update on the genous technology by Federico Piscione, M.D., of Fede... on the data we've seen with the real-world use of genous and in recent clinical trials, we believe that the...

OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial

...s who received OrbusNeich's pro-healing stent, the genous Bio-engineered R stent, had significantly fewer ma...ES. "Our findings suggest that the deployment of genous stents in a consecutive series of high-risk patien...otoxic agents to inhibit neointimal proliferation, genous attracts circulating endothelial progenitor cells ...

Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) and Boston Scientific's Taxus(R) Stent in Patients at High Risk of Restenosis

...follow-up, the majority of patients who received a genous stent were on single antiplatelet therapy, whi... therapy -- One acute stent thrombosis in the genous arm, while there was one acute, one subacute ... for the large-scale TRIAS study that will compare genous to both drug-eluting and bare metal stents." For ...
Genous in Biological Technology

OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients

...arget lesion revascularization (TLR) rate with the genous treated patient group compared with patients recei...mbosis events at any time period in the 98 patient genous group with only one month of dual antiplatelet the...e composite of death and myocardial infarction for genous was 4.1% versus 7.3% for Taxus. "Within a month w...

Interim Analysis of Data from e-HEALING Registry of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008

...om e-HEALING, a global post-marketing surveillance registry of OrbusNeich's genous Bio-engineered R stent, will be presented next week at the American Heart A...reatment of vascular diseases. The company's product portfolio includes the genous Bio-engineered R stent, an antibody-coated device that is the first-ever st...

OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports

...rnal (2008; Vol. 155, Issue 1: 128-132). The paper, based on a study of 120 acute ST-elevation myocardial infarction (STEMI) patients who received a genous stent, reports there was no incidence of late thrombosis and that the revascularization rate of 2.5% at six months is highly acceptable when compared ...
Other Tags
(Date:7/28/2014)... WA (PRWEB) July 28, 2014 According to ... Vkool.com, this is a comprehensive fitness guide that teaches men ... per week. , Vkool reveals in its review that ... discover:, Ways to gain the maximum ... to build muscle and avoid fat gain , ...
(Date:7/28/2014)... July 28, 2014 TherapySites, ... health professionals, announced today its affiliation with the ... This new relationship allows TherapySites to continue to extend ... benefits and promotional offers. , “There has been a ... today. With nearly 3 billion Internet users, it ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 CW4K was ... First Lady Michelle Obama and Partnership for a ... as they join the group's DrinkUP effort, ... water, more often. , The seven organizations added ... Nalgene® Outdoor Products, S’well Bottle, Santa Clara Valley Water ...
(Date:7/28/2014)... July 28, 2014 Footwear etc. is ... styles from Mephisto. With shoes, sandals, and boots that ... products continually provide handmade comfort shoes and ... women have come to rely on the superb value, ... Mephisto shoes and sandals contain the highest quality materials ...
(Date:7/28/2014)... Washington, DC (PRWEB) July 28, 2014 ... beyond, many are looking to private exchanges. “Private ... the August 6 webinar from Atlantic Information Services, will ... insurers’ private exchange strategies for the future. , Barbara ... from PwC with extensive experience in the private exchange ...
Breaking Medicine News(10 mins):Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 2Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 3Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 3Health News:Footwear etc. Highlights Phenomenal Models of Mephisto Shoes 2Health News:Footwear etc. Highlights Phenomenal Models of Mephisto Shoes 3Health News:Three PwC Consultants to Offer Insurers Successful Strategies for Private Exchanges 2
(Date:7/27/2014)... vitro study has revealed that nicotine and cotinine, a ... by a certain carcinogen in smoke. , The carcinogen ... tobacco leaves and ultimately ends up in the tobacco ... and liver, where it is activated by a variety ... mice has revealed that nicotine can partially interfere with ...
(Date:7/27/2014)... asteroid strike that wiped them out if it had ... say. , A fresh study using up-to-date fossil records ... a new narrative of the prehistoric creatures, demise, some ... the few million years before a 10km-wide asteroid struck ... This included extensive volcanic activity, changing sea levels and ...
(Date:7/27/2014)... to date, researchers from the U.K. provide national, regional, ... virus (HCV). Findings published in Hepatology, a journal of ... indicate that genotype 1 is the most prevalent worldwide, ... reside in East Asia. Genotype 3, at just over ... by genotypes 2, 4, 6, and 5. , ...
Breaking Biology News(10 mins):Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2Dinosaurs fell victim to perfect storm of events, study shows 2Hepatitis C virus genotype 1 is most prevalent worldwide 2
Other Contents